Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine.

類似資料

• Pharmacokinetic Evaluation of Oral Levofloxacin in Human Immunodeficiency Virus-Infected Subjects Receiving Concomitant Antiretroviral Therapy
  著者:: Villani, P., 等
  出版事項: (2001)
• Pharmacokinetics and safety of levofloxacin in patients with human immunodeficiency virus infection.
  著者:: Goodwin, S D, 等
  出版事項: (1994)
• Absence of age and gender effects on the pharmacokinetics of a single 500-milligram oral dose of levofloxacin in healthy subjects.
  著者:: Chien, S C, 等
  出版事項: (1997)
• Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses.
  著者:: Chien, S C, 等
  出版事項: (1997)
• Pharmacokinetics and Safety of High-Dose and Extended-Interval Regimens of Levofloxacin in Human Immunodeficiency Virus-Infected Patients
  著者:: Piscitelli, Stephen C., 等
  出版事項: (1999)